NCNA - NuCana PLC

https://www.nucana.com

Momentum: Bearish

Recent News

NuCana Announces Plan to Implement ADS Ratio Change

Business Insider • 2 months ago • score: 0.11

EDINBURGH, United Kingdom, July 11, 2025 ( GLOBE NEWSWIRE ) -- NuCana plc ( NASDAQ: NCNA ) ( "NuCana" or the "Company" ) announced plans to change the ratio of its American Depository Shares ( "ADSs" ) to its ordinary shares from one ( 1 ) ADS, representing twenty-five ( 25 ) ordinary shares, to ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

NuCana plc, a clinical-stage biopharmaceutical company, is dedicated to the development of products for the treatment of cancer. The company is headquartered in Edinburgh, the United Kingdom.

52W High

$1650.00

52W Low

$2.78

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.39

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

0.30

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

0.55

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

0.00%

Institutions (25–75% balanced)

0.24%

Shares Outstanding

1,908,100

Float

9,539,268,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

EPS (TTM)

-1747.21

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-5.68%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

-1.1914

-1.3580

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025